The viral proteins, latent membrane protein 1 (LMP1) and latent membrane protein 2 (LMP2), are expressed in many of the malignancies associated with EBV. The immunoglobulin heavy chain promoter/enhancer (Ig- LMPI) transgenic mice develop clonal B-cell lymphomas that can be passaged xenografts in SCID mice. The growth characteristics in vitro and lymphoma development of these mice, the lg-LMP2 mice, and doubly transgenic lg-LMP1/LMP2 mice have been determined. To evaluate the effects of LMP1 on epithelial cell growth, we have produced transgenic mice that express LMP1 under the control of the keratin 14 (K14) promoter. In classical tumor initiation and promotion analyses, LMP1 functions as a tumor promoter with a possible role in tumor progression. K14-LMP2 transgenic mice do not have enhanced papilloma or carcinoma development, however, carcinoma development is increased in the K14-LMP1/LMP2 double transgenic mice.
Our specific aims are:
Aim 1) The transgenic LMP1 + lymphocytes, LMP1 + lymphomas, LMP2 transgenic lymphocytes, and LMP1/LMP2+ lymphomas will be further characterized : A). Analyze the activated form of c-rel in the LMP1+ lymphomas using immunoprecipitation and proteomics to identify its binding partners. B.) Identify c-rel and STAT3 regulated genes in the lymphomas using chromatin immunoprecipitation and deep sequencing. C.) Assess the effects of inhibition of specific activated pathways including NFkB, Akt, Stat3, and in collaboration with Dr. Pagano, UCHL1, on activation of specific transcription factors and on growth and metastasis in vivo. D.) Confirm potential targets identified by microarray analysis using targeted arrays in the Virogenomics Core and determine the effects of inhibition of NFkB, Akt, Stat3, and Erk on the activation of specific genes within these pathways.
Aim 2) Determine the effects of LMP1 and LMP2 on mouse cellular miRNA expression using the Virogenomics Core. Assess the effects of expression of the cellular miRNAs on the growth of transgenic cells.
Aim 3) Characterize the K14 LMP1 and LMP2 squamous cell carcinomas: A.) Determine the effects on cellular expression using 2-D fluorescence difference gel electrophoresis and mass spectrometry and mRNA expression arrays. Identify effects of the viral genes on specific cellular regulatory pathways using expression microarray analyses. B.) Test the hypothesis that LMP1 and LMP2 will transform K14 mutant ras transgenic mice and induce carcinoma development.

Public Health Relevance

The Epstein Barr virus is an important human pathogen that is a causative factor in the development of many cancers. Two of the viral proteins have major effects on cell growth. This study will analyze transgenic mice that express these proteins and develop lymphoma and carcinoma. The study of these tumors will identify how these proteins control cell growth and test potential, novel therapies in vivo in the transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019014-34
Application #
8504912
Study Section
Special Emphasis Panel (ZCA1-RPRB-0)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
34
Fiscal Year
2013
Total Cost
$273,889
Indirect Cost
$78,954
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Eason, Anthony B; Sin, Sang-Hoon; Lin, Carolina et al. (2016) Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human. Oncotarget 7:63504-63513
El-Mallawany, Nader Kim; Kamiyango, William; Slone, Jeremy S et al. (2016) Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One 11:e0153335
Schifano, Jason M; Corcoran, Kathleen; Kelkar, Hemant et al. (2016) Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus. J Virol :
Sin, Sang-Hoon; Kang, Sun Ah; Kim, Yongbaek et al. (2016) Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation. J Virol 90:2150-4
Westmoreland, Katherine D; Stanley, Christopher C; Montgomery, Nathan D et al. (2016) Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer :
Dittmer, Dirk P; Damania, Blossom (2016) Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy. J Clin Invest 126:3165-75
Ma, Zhe; Damania, Blossom (2016) The cGAS-STING Defense Pathway and Its Counteraction by Viruses. Cell Host Microbe 19:150-8
Bhatt, Aadra Prashant; Wong, Jason P; Weinberg, Marc S et al. (2016) A viral kinase mimics S6 kinase to enhance cell proliferation. Proc Natl Acad Sci U S A 113:7876-81
Damania, Blossom (2016) A Virological Perspective on Cancer. PLoS Pathog 12:e1005326
Bermek, Oya; Willcox, Smaranda; Griffith, Jack D (2015) DNA replication catalyzed by herpes simplex virus type 1 proteins reveals trombone loops at the fork. J Biol Chem 290:2539-45

Showing the most recent 10 out of 285 publications